{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:10:23Z","timestamp":1785449423051,"version":"3.56.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T00:00:00Z","timestamp":1352160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/npp.2012.231","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T14:53:18Z","timestamp":1354719198000},"page":"664-672","source":"Crossref","is-referenced-by-count":80,"title":["Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder"],"prefix":"10.1038","volume":"38","author":[{"given":"Joel","family":"Jakobsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Johan Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette G M","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Land\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,6]]},"reference":[{"key":"BFnpp2012231_CR1","first-page":"338","volume":"1","author":"AR Bailey","year":"2008","unstructured":"Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD et al (2008). Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis. Int J Clin Exp Med 1: 338\u2013344.","journal-title":"Int J Clin Exp Med"},{"key":"BFnpp2012231_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMra035354","volume":"351","author":"RH Belmaker","year":"2004","unstructured":"Belmaker RH (2004). Bipolar disorder. N Engl J Med 351: 476\u2013486.","journal-title":"N Engl J Med"},{"key":"BFnpp2012231_CR3","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","volume":"35","author":"M Berk","year":"2011","unstructured":"Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M et al (2011). Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35: 804\u2013817.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2012231_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010). Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131\u2013144.","journal-title":"Nat Rev Neurol"},{"key":"BFnpp2012231_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.neuropharm.2010.12.027","volume":"62","author":"NJ Bradshaw","year":"2012","unstructured":"Bradshaw NJ, Porteous DJ (2012). DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology 62: 1230\u20131241.","journal-title":"Neuropharmacology"},{"key":"BFnpp2012231_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1192\/bjp.180.4.320","volume":"180","author":"JT Cavanagh","year":"2002","unstructured":"Cavanagh JT, Van Beck M, Muir W, Blackwood DH (2002). Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 180: 320\u2013326.","journal-title":"Br J Psychiatry"},{"key":"BFnpp2012231_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/ageing\/27.2.181","volume":"27","author":"B Cooper","year":"1998","unstructured":"Cooper B, Holmes C (1998). Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study. Age Ageing 27: 181\u2013188.","journal-title":"Age Ageing"},{"issue":"3","key":"BFnpp2012231_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neulet.2005.12.085","volume":"398","author":"Angelo B.M. Cunha","year":"2006","unstructured":"Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA et al (2006). Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398 215\u2013219.","journal-title":"Neuroscience Letters"},{"key":"BFnpp2012231_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s00401-001-0496-2","volume":"103","author":"R Damadzic","year":"2002","unstructured":"Damadzic R, Shuangshoti S, Giblen G, Herman MM (2002). Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Acta Neuropathol 103: 488\u2013494.","journal-title":"Acta Neuropathol"},{"key":"BFnpp2012231_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1600-0447.2010.01586.x","volume":"122","author":"CJ Ekman","year":"2010","unstructured":"Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M (2010). Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis. Acta Psychiatr Scand 122: 507\u2013515.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp2012231_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11065-005-6254-9","volume":"15","author":"M Fioravanti","year":"2005","unstructured":"Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L (2005). A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev 15: 73\u201395.","journal-title":"Neuropsychol Rev"},{"key":"BFnpp2012231_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/gps.2575","volume":"26","author":"GB Frisoni","year":"2011","unstructured":"Frisoni GB, Prestia A, Geroldi C, Adorni A, Ghidoni R, Amicucci G et al (2011). Alzheimer's CSF markers in older schizophrenia patients. Int J Geriatr Psychiatry 26: 640\u2013648.","journal-title":"Int J Geriatr Psychiatry"},{"key":"BFnpp2012231_CR13","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00018-007-7220-x","volume":"64","author":"F Hernandez","year":"2007","unstructured":"Hernandez F, Avila J (2007). Tauopathies. Cell Mol Life Sci 64: 2219\u20132233.","journal-title":"Cell Mol Life Sci"},{"key":"BFnpp2012231_CR14","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1073\/pnas.0600948103","volume":"103","author":"JS Jacobsen","year":"2006","unstructured":"Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M et al (2006). Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103: 5161\u20135166.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2012231_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2011.00016","volume":"4","author":"RS Jope","year":"2011","unstructured":"Jope RS (2011). Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front Mol Neurosci 4: 16.","journal-title":"Front Mol Neurosci"},{"key":"BFnpp2012231_CR16","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archpsyc.65.9.1017","volume":"65","author":"MJ Kempton","year":"2008","unstructured":"Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM (2008). Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 65: 1017\u20131032.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2012231_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-5618.2008.00435.x","volume":"10","author":"JZ Konarski","year":"2008","unstructured":"Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA (2008). Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord 10: 1\u201337.","journal-title":"Bipolar Disord"},{"key":"BFnpp2012231_CR18","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1038\/emboj.2010.211","volume":"29","author":"I Kuperstein","year":"2010","unstructured":"Kuperstein I, Broersen K, Benilova I, Rozenski J, Jonckheere W, Debulpaep M et al (2010). Neurotoxicity of Alzheimer\u2019s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J 29: 3408\u20133420.","journal-title":"EMBO J"},{"key":"BFnpp2012231_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/mp.2008.84","volume":"15","author":"P Lewczuk","year":"2010","unstructured":"Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J et al (2010). Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer\u2019s disease: a multicenter study. Mol Psychiatry 15: 138\u2013145.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2012231_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000012361","volume":"69","author":"A Martinez-Aran","year":"2000","unstructured":"Martinez-Aran A, Vieta E, Colom F, Reinares M, Benabarre A, Gasto C et al (2000). Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 69: 2\u201318.","journal-title":"Psychother Psychosom"},{"key":"BFnpp2012231_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000086320","volume":"74","author":"A Martinez-Aran","year":"2005","unstructured":"Martinez-Aran A, Vieta E, Colom F, Torrent C, Reinares M, Goikolea JM et al (2005). Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 74: 295\u2013302.","journal-title":"Psychother Psychosom"},{"key":"BFnpp2012231_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1176\/appi.ajp.161.2.262","volume":"161","author":"A Martinez-Aran","year":"2004","unstructured":"Martinez-Aran A, Vieta E, Reinares M, Colom F, Torrent C, Sanchez-Moreno J et al (2004). Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 161: 262\u2013270.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2012231_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2377-10-51","volume":"10","author":"N Mattsson","year":"2010","unstructured":"Mattsson N, Bremell D, Anckarsater R, Blennow K, Anckarsater H, Zetterberg H et al (2010a). Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10: 51.","journal-title":"BMC Neurol"},{"key":"BFnpp2012231_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2377-10-51","volume":"10","author":"N Mattsson","year":"2010","unstructured":"Mattsson N, Bremell D, Anckarsater R, Blennow K, Anckarsater H, Zetterberg H et al (2010b). Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10: 51.","journal-title":"BMC Neurol"},{"key":"BFnpp2012231_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.neures.2009.11.012","volume":"66","author":"N Mattsson","year":"2010","unstructured":"Mattsson N, Savman K, Osterlundh G, Blennow K, Zetterberg H (2010c). Converging molecular pathways in human neural development and degeneration. Neurosci Res 66: 330\u2013332.","journal-title":"Neurosci Res"},{"key":"BFnpp2012231_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","volume":"68","author":"KR Merikangas","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA et al (2011). Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68: 241\u2013251.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2012231_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuron.2011.04.009","volume":"70","author":"M Morris","year":"2011","unstructured":"Morris M, Maeda S, Vossel K, Mucke L (2011). The many faces of tau. Neuron 70: 410\u2013426.","journal-title":"Neuron"},{"key":"BFnpp2012231_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1503\/jpn.090180","volume":"35","author":"SK Olsson","year":"2010","unstructured":"Olsson SK, Samuelsson M, Saetre P, Lindstrom L, Jonsson EG, Nordin C et al (2010). Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder. J Psychiatry Neurosci 35: 195\u2013199.","journal-title":"J Psychiatry Neurosci"},{"key":"BFnpp2012231_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1212\/WNL.0b013e318221ad47","volume":"77","author":"R Perneczky","year":"2011","unstructured":"Perneczky R, Tsolakidou A, Arnold A, Diehl-Schmid J, Grimmer T, Forstl H et al (2011). CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease. Neurology 77: 35\u201338.","journal-title":"Neurology"},{"key":"BFnpp2012231_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature01640","volume":"423","author":"CJ Phiel","year":"2003","unstructured":"Phiel CJ, Wilson CA, Lee VM, Klein PS (2003). GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435\u2013439.","journal-title":"Nature"},{"key":"BFnpp2012231_CR31","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","volume":"169","author":"N Pomara","year":"2012","unstructured":"Pomara N, Bruno D, Sarreal AS, Hernando RT, Nierenberg J, Petkova E et al (2012). Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder. Am J Psychiatry 169: 523\u2013530.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2012231_CR32","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F et al (2008). Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med 205: 2781\u20132789.","journal-title":"J Exp Med"},{"key":"BFnpp2012231_CR33","doi-asserted-by":"publisher","first-page":"e20405","DOI":"10.1371\/journal.pone.0020405","volume":"6","author":"B Ray","year":"2011","unstructured":"Ray B, Long JM, Sokol DK, Lahiri DK (2011). Increased secreted amyloid precursor protein-alpha (sAPPalpha) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One 6: e20405.","journal-title":"PLoS One"},{"key":"BFnpp2012231_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2006.02.016","volume":"93","author":"LJ Robinson","year":"2006","unstructured":"Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, Ferrier IN et al (2006). A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93: 105\u2013115.","journal-title":"J Affect Disord"},{"key":"BFnpp2012231_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12017-012-8171-4","volume":"14","author":"C Rosen","year":"2012","unstructured":"Rosen C, Andreasson U, Mattsson N, Marcusson J, Minthon L, Andreasen N et al (2012). Cerebrospinal fluid profiles of amyloid beta-related biomarkers in Alzheimer's disease. Neuromolecular Med 14: 65\u201373.","journal-title":"Neuromolecular Med"},{"key":"BFnpp2012231_CR36","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00702-009-0300-3","volume":"116","author":"E Ryden","year":"2009","unstructured":"Ryden E, Johansson C, Blennow K, Landen M (2009a). Lower CSF HVA and 5-HIAA in bipolar disorder type 1 with a history of childhood ADHD. J Neural Transm 116: 1667\u20131674.","journal-title":"J Neural Transm"},{"key":"BFnpp2012231_CR37","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0447.2009.01399.x","volume":"120","author":"E Ryden","year":"2009","unstructured":"Ryden E, Thase ME, Straht D, Aberg-Wistedt A, Bejerot S, Landen M (2009b). A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 120: 239\u2013246.","journal-title":"Acta Psychiatr Scand"},{"key":"BFnpp2012231_CR38","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0006-3223(03)00165-3","volume":"53","author":"GS Sachs","year":"2003","unstructured":"Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR et al (2003). Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 53: 1028\u20131042.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2012231_CR39","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4088\/JCP.08m04302","volume":"70","author":"J Sanchez-Moreno","year":"2009","unstructured":"Sanchez-Moreno J, Martinez-Aran A, Colom F, Scott J, Tabares-Seisdedos R, Sugranyes G et al (2009). Neurocognitive dysfunctions in euthymic bipolar patients with and without prior history of alcohol use. J Clin Psychiatry 70: 1120\u20131127.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2012231_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 88: 791\u2013804.","journal-title":"Addiction"},{"key":"BFnpp2012231_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.20508","volume":"58","author":"NS Schoonenboom","year":"2005","unstructured":"Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA et al (2005). Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same? Ann Neurol 58: 139\u2013142.","journal-title":"Ann Neurol"},{"issue":"Suppl 20","key":"BFnpp2012231_CR42","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22\u201333 quiz 34-57.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2012231_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(03)00089-3","volume":"70","author":"PR Turner","year":"2003","unstructured":"Turner PR, O\u2019Connor K, Tate WP, Abraham WC (2003). Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70: 1\u201332.","journal-title":"Prog Neurobiol"},{"key":"BFnpp2012231_CR44","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.1523\/JNEUROSCI.1445-10.2010","volume":"30","author":"TL Young-Pearse","year":"2010","unstructured":"Young-Pearse TL, Suth S, Luth ES, Sawa A, Selkoe DJ (2010). Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development. J Neurosci 30: 10431\u201310440.","journal-title":"J Neurosci"},{"key":"BFnpp2012231_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1023\/A:1004632206684","volume":"71","author":"CA Zarate","year":"2000","unstructured":"Zarate CA, Tohen M, Land M, Cavanagh S (2000). Functional impairment and cognition in bipolar disorder. Psychiatr Q 71: 309\u2013329.","journal-title":"Psychiatr Q"},{"key":"BFnpp2012231_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"YW Zhang","year":"2011","unstructured":"Zhang YW, Thompson R, Zhang H, Xu H (2011). APP processing in Alzheimer's disease. Mol Brain 4: 3.","journal-title":"Mol Brain"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2012231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2012231","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2012231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:43:28Z","timestamp":1684453408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2012231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,6]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFnpp2012231"],"URL":"https:\/\/doi.org\/10.1038\/npp.2012.231","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,6]]}}}